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OBJECTIVES: To identify appropriate screening condi-
tions, stratified according to age and vulnerability, to
prevent functional decline in older people.
DESIGN: A RAND/University of California at Los Ange-
les appropriateness method.
SETTING: The Netherlands.
PARTICIPANTS: A multidisciplinary panel of 11 experts.
MEASUREMENTS: The panelists assessed the appropri-
ateness of screening for 29 conditions mentioned in
guidelines from four countries, stratified according to age
(60–74, 75–84,  85) and health status (general, vital, and
vulnerable) and received a literature overview for each
condition, including the guidelines and up-to-date litera-
ture. After an individual rating round, panelists discussed
disagreements and performed a second individual rating.
The median of the second ratings defined the appropriate-
ness of screening.
RESULTS: The panel rated screening to be appropriate in
three of the 29 conditions, indicating that screening was
expected to prevent functional decline. Screening for insuf-
ficient physical activity was considered appropriate for all
three age and health groups. Screening for cardiovascular
risk factors and smoking was considered appropriate for
the general and vital population aged 60 to 74. Of the 261
ratings, 63 (24%) were classified as uncertain, of which 42
(67%) concerned the vulnerable population. The panelists
considered conditions inappropriate mainly because of lack
of an adequate screening tool or lack of evidence of effec-
tive interventions for positive screened persons.
CONCLUSION: The expert panel considered screening
older people to prevent functional decline appropriate for
insufficient physical activity and smoking and cardiovascu-
lar risk in specific groups. For other conditions, sufficient
evidence does not support screening. Based on their experi-
ence, panelists expected benefit from developing tests and
interventions, especially for vulnerable older people. J Am
Geriatr Soc 60:42–50, 2012.
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The interest in screening community-dwelling olderpeople is increasing,1–4 and several guidelines for such
screening have been issued.5–13 Screening is a strategy used
in a population to detect a disease, risk factor, or ailment
in individuals with unrecognized signs or symptoms. In
general, the intention of screening is to identify the
screened condition early, enabling earlier intervention and
management to postpone diseases and death, but older
people (especially frail older people) do not always benefit
from screening because of their shorter natural life expec-
tancy and their lack of physiological reserve to tolerate the
invasive interventions called for after screening.4
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For these older populations, screening can have an
additional aim. In this age group, the aim is also to con-
tribute to healthy aging, which is a prominent theme in
current health policy.14–17 Healthy aging is not only a mat-
ter of maintaining good physical and mental health, but
also of older people remaining independent and participat-
ing in social activities. As the general health status of older
people declines, values such as functioning in daily life and
well-being become more important than life expectancy.18
Therefore, it was postulated that a screening approach to
community-dwelling older people would be appropriate if
it aimed at preventing and postponing functional decline,19
but current screening guidelines tend to ignore this aim. In
addition, specific research on screening in older people is
scarce. Therefore, screening guidelines often have to
address a lack of age-specific evidence.
In the present study, an expert panel assessed the con-
tribution of screening of community-dwelling older people
to the prevention of functional decline using the RAND/
University of California at Los Angeles (UCLA) appropri-
ateness method.20–22 This method was chosen because a
preceding literature search showed that the available scien-
tific evidence was inconclusive. This RAND/UCLA appro-
priateness method was specifically developed to combine
the available scientific evidence with the collective judg-
ment of experts. To select conditions for this study, the
content of general guidelines and protocols on screening
and prevention was used. The appropriateness of screening
the older population to prevent functional decline was
assessed for several conditions by applying the most fre-
quently used criteria for screening of this older population,
formulated in 1968 by Wilson and Jungner (Table 1).23
Because the older population is heterogeneous, and it was
hypothesized that age and vulnerability would be impor-
tant determinants in assessing appropriateness, the present
study stratified according to age24 and vulnerability.25,26
METHODS
The RAND/UCLA appropriateness method was used.20,22
The method was designed in the mid-1980s, primarily as
an instrument to enable measurement of the overuse and
underuse of medical and surgical procedures. Since then,
this method has been used for many topics and its validity
and reliability have been demonstrated in a wide variety
of medical and preventive procedures that lack a
firm evidence base.27–29 For a detailed description see
Appendix S1.
Selection of Screening Conditions and Literature
Review
Guidelines and protocols on screening and prevention were
used to select conditions for this study. Conditions were
selected from three Dutch guidelines and protocols on
screening and prevention5–7 and from English-language
guidelines of five leading healthcare institutes in the United
States, Australia, and Great Britain.8–13 Two of these
documents were specifically developed for vulnerable older
people,6,10 but none of them was specifically aimed at pre-
vention of functional decline.
A screening condition was considered eligible if it was
recommended in one or more of these guidelines; this
resulted in 29 conditions. To compile an overview of the
evidence for each of these conditions, the guidelines and
the literature references on which these guidelines were
based were collected. For each condition separately, a sci-
entist with expertise in the content of that condition was
asked to comment on the guidelines and reference lists and
to add up-to-date information if available. These files, one
for each condition, formed the evidence package for the
expert panel. The panelists used the literature overview
from the evidence packages and their expertise to weigh
the evidence for screening of each condition.
To acquire an overview of the differences between the
guidelines and protocols, two researchers (YD, VvdM)
independently divided the screening recommendations of
the guidelines into the following groups: positive advice
for older people in general, positive advice for specific
groups of older people (people at risk, as defined in the
guidelines), negative advice, insufficient evidence to give
advice, or screening not mentioned in the guideline. Any
disagreement between the two researchers was settled by
consensus discussions or by a third party (JG).
Expert Panel and Rating Process
For the panel, 11 experts from disciplines involved in geri-
atric care and screening were recruited from eight univer-
sity medical centers: seven physicians with scientific
expertise, of whom four were general practitioners (JD,
JM, HS, AW), two were clinical geriatricians (SdR, RW),
and one was a nursing home physician (KdV); three scien-
tists, of whom two were public health scientists (MG, FS),
and one was a nursing scientist (MS); and an expert from
Vilans, a Dutch Knowledge Centre on Ageing (RvO). In
brief, the RAND/UCLA appropriateness method entails
two rounds of independent ratings by panelists, with one
face-to-face group discussion (supervised by an indepen-
dent chairman) between these rounds.22 The panelists
rated the appropriateness of screening for each condition.
The score of each panelist was equally weighed in the final
ratings. One month before the meeting, panelists received
the evidence packages, definitions of the terms used for the
procedure, the criteria of Wilson and Jungner,23 and the
rating sheets.
Table 1. Wilson and Jungner Criteria for Screening23
1 The condition sought should be an important health problem
2 There should be an accepted treatment for patients
with recognized disease
3 Facilities for diagnosis and treatment should be available
4 There should be a recognizable latent or early symptomatic stage
5 There should be a suitable test or examination
6 The test should be acceptable to the population
7 The natural history of the condition, including development from
latent to declared disease, should be adequately understood
8 There should be an agreed policy on whom to treat as patients
9 The cost of case-finding (including diagnosis and treatment of
patients diagnosed) should be economically balanced in relation
to possible expenditure on medical care as a whole
10 Case-finding should be a continuing process and not a “once and
for all” project
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In accordance with the RAND/UCLA appropriateness
method, the expert panel was instructed to weigh evidence
and to use their expert opinion for assessment of the con-
tribution of screening to the prevention or postponement
of functional decline for each specific condition. The pan-
elists followed the previously developed criteria of Wilson
and Jungner for each condition; they investigated whether
evidence was present to fulfill the criteria for a specific
condition, taking their expert opinion about a potential
benefit into account.
Prevention or postponement of functional decline was
defined as supporting the ability of older people to func-
tion as independently as possible.18 Screening was consid-
ered appropriate if the health benefits exceed the health
risks by a margin that was sufficiently wide to make the
procedure worth doing.20,22,30 The expert panel was asked
to rate each condition for each of the three age groups (60
–74, 75–84, 85) and for each of the three levels of
health status (general, vital, and vulnerable).
In the present study, the general population was
defined as the overall older population. This population
was split into a vulnerable population with a high preva-
lence of diseases and disorders, a poorer prognosis, disabil-
ity of various kinds, multiple problems simultaneously,
and a vital population that was defined as nonvulnerable.
The rating process resulted in nine ratings per condi-
tion. Rating was done on a 1- to 9-point Likert scale
(1 = extremely inappropriate, 5 = uncertain or equivocal,
and 9 = extremely appropriate to screen).
The rating sheets were returned by mail and tabulated,
and the results of the first-round rating were used to guide
a subsequent 2-day face-to-face meeting of all panelists in
March 2009. At the face-to-face meeting, headed by a
moderator experienced in the RAND/UCLA appropriate-
ness method (HR),6,31 each panelist received a report of
his or her own first-round ratings, a frequency distribution,
and the median of the whole panel. The individual ratings
were blinded to other group members. Every condition
was discussed to identify areas of disagreement, to high-
light evidence not cited in the literature reviews, and to
clarify specific definitions or wording of the conditions. In
addition, panelists could revise existing conditions to bet-
ter fit their judgment and could propose new conditions.
The Wilson and Jungner criteria were used as leading prin-
ciples in the discussion. After these discussions, in which
the assessment was based on the combination of evidence
and expert opinion, each panelist rerated all of the condi-
tions on the 1- to 9-point scale. The entire discussion was
audiotaped, and two researchers (YD, JG) made field
notes. After the session, a report was written and sent to
the panelists for their comments. These documents were
used in the analysis to explain the outcomes of the ratings.
Appropriateness
The final appropriateness judgments were based on the
median panel rating and level of disagreement for each
condition in the second round, using the following defini-
tions: all conditions with a median rating of 7 to 9, rated
without disagreement, were classified as appropriate; those
with a median rating of 1 to 3, rated without disagree-
ment, were classified as inappropriate; and those with a
median rating of 4 to 6, as well as all conditions rated
with disagreement, regardless of the median, were classi-
fied as uncertain. A condition was considered to be rated
with disagreement when at least three panelists rated it in
the 1 to 3 range, and at least three panelists rated it in the
7 to 9 range.32
RESULTS
Recommendations by Guidelines
The guidelines for screening5–13 showed a great variety of
conditions and screening advice. None of the individual 29
conditions was addressed in all screening guidelines. The
most frequently advised screening was for smoking status,
followed by cardiovascular risk factors, malnutrition, and
overweight. For abdominal aortic aneurysm, cognitive
impairment, depression and anxiety, diabetes mellitus, and
osteoporosis, the guidelines gave conflicting recommenda-
tions; some advised screening for these conditions, whereas
others warned against screening. Table 2 gives an over-
view of the recommendations in the guidelines; the condi-
tions included in the second rating process are also shown.
RAND/UCLA appropriateness method
In the first round with 29 conditions, there was disagree-
ment in 23% (59/261) of the ratings. In the second round,
after the face-to-face meeting, the disagreement was
reduced to 3.4% (9/261). During the discussion sessions,
three conditions were dropped because they were too diffi-
cult to define in an unequivocal way (social well-being,
social support, and spare time), two conditions were
divided into two parts (nutrition into malnutrition and
undernutrition and burden of the informal caregiver into
burden of the screened person as informal caregiver and
burden of the informal caregivers around the screened per-
son). One specification of a subgroup was added to
abdominal aortic aneurysm and was discussed separately
(abdominal aortic aneurysm in (ex-)smoking men). As a
result, the second round also addressed 29 conditions.
Appropriateness
For the older population in general, screening for insuffi-
cient physical activity for all three age groups and screen-
ing for cardiovascular risk and smoking for aged 60 to 74
were rated appropriate, indicating that screening was
expected to prevent functional decline (Table 3). Screening
was rated uncertain for hearing impairment (all three age
groups), colorectal cancer (60–74 and 75–84), the burden
of the screened person as informal caregiver, smoking sta-
tus (75–84 and 85), cardiovascular risk factors (75–84)
and abdominal aortic aneurysm in (ex-)smoking men (60–
74), indicating serious doubts. For all the other conditions,
screening of the general older population was considered
inappropriate.
Influence of Vulnerability
Screening for insufficient physical activity was considered
appropriate for all older persons (Table 3). Cardiovascular
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screening and screening for smoking status were rated
appropriate in the vital population aged 60 to 74. Uncer-
tainty (median range: 4–6 or disagreement) about the
appropriateness was rated in 24% (63/261) of the scores.
Of all uncertain outcomes, 67% concerned the vulnerable
population. The panelists argued that lack of sufficient evi-
dence to fulfill the criteria of Wilson and Jungner is mainly
due to lack of research in this population as such. Based
on their expertise in clinical practice, they assumed that
development of specific tests and interventions for this
group may generate evidence and will lead to benefits of
screening, especially when the screening approach is
embedded in regular care.
Influence of Age
In contrast to expectations, the age category of the persons
did not strongly influence the ratings of the panel
(Table 3). Exceptions to this were cardiovascular screening
and smoking status (influence of age in all three groups of
health status); abdominal aortic aneurysm in (ex-)smoking
men, colorectal cancer, burden of the screened person as
informal caregiver (influence of age in the general and vital
population); and urinary incontinence (influence of age in
the vital population). For cardiovascular screening of older
people, the main problem is lack of a suitable test. The
panelists considered that Framingham Study scores were
not valid for the older age categories because these scores
do not predict cardiovascular mortality in the oldest old.33
For smoking, abdominal aortic aneurysm in (ex-)smoking
men, and colorectal cancer, the importance of screening
declines with increasing age for different reasons (e.g., for
smoking, there is insufficient evidence for the yield of stop-
ping at older age; for aneurysm, the risk of a surgical pro-
cedure increases with age; and for colorectal cancer, the
natural history at older age is unknown, and the risk of
surgery increases with age). In contrast, the appropriate-
ness of screening for urinary incontinence and for the bur-
den of the screened person as informal caregiver increases
with age, mainly because the yield increases.
Reasons for Uncertainty and Inappropriateness
When the panelists expected benefits of screening accord-
ing to their expert opinion, although evidence was lacking,
they rated the condition in the uncertain range. Screening
for a condition was rated in the inappropriate range when
evidence from literature was against screening or when evi-
dence was lacking and the panelists expected no benefit
according to their expert opinion. In the panel discussions,
the most frequently used argument for inappropriateness
was lack of evidence for effective interventions (Wilson
and Jungner criterion 2).23 There was sometimes a per-
ceived lack of a rational evidence-based intervention (e.g.,
dementia, smelling problems), and sometimes it was
assumed that adherence to advice or treatment after a
positive screening would be too low on the basis of experi-
ence or circumstantial scientific evidence (e.g., urinary
incontinence, hearing aid, alcohol abuse). Furthermore, the
panel thought some conditions to be of insufficient impor-
tance (Wilson and Jungner criterion 1) because the preva-
lence was too low to warrant screening (e.g., skin cancer
in the Netherlands) or the relevance of screening for the
condition was not considered to be high enough (e.g., pain
and sleeping disorders). In general, the panelists expected
that people with these problems and motivation for subse-
quent interventions would already be seeking help. For
some conditions, a suitable test or examination was lack-
ing (Wilson and Jungner criterion 5): too many false posi-
tives (fecal occult blood test for colorectal cancer) or too
many false negatives (alcohol abuse, osteoporosis), prob-
lems with acceptance of the test (colonoscopy), or test not
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DISCUSSION
Principle Findings
Despite increasing interest in screening of community-
dwelling older people and the recommendations in guide-
lines, the Dutch panel considered screening of only a few
conditions to be appropriate. Screening for insufficient
physical activity to prevent functional decline is appropri-
ate for all older persons. Screening for cardiovascular risk
factors and smoking status are considered useful for the
general older population aged 60 to 74 but not for vulner-
able older people in the same age range. There is insuffi-
cient evidence to support screening for the other
investigated conditions.
During the face-to-face meeting, the experts empha-
sized that an uncertain or inappropriate rating does not
mean that the condition is irrelevant but that there was
insufficient evidence to recommend an active screening
approach. To conclude that screening contributes to the
prevention of functional decline, screening must at least
approximately meet the criteria of Wilson and Jungner.
When evidence to fulfill the criteria of Wilson and Jungner
was lacking or inconclusive, the experts’ opinions about a
potential benefit to prevent functional decline were taken
into account. It was not thought that strong evidence sup-
ported interventions that merely stimulate well-being (e.g.,
interventions to address loneliness), although based on
experience, the panelists expected at least some benefit
from these interventions.
Vulnerability was considered to be an important
factor in the determination of appropriateness of screen-
ing. For 11 of the 29 conditions, the panelists were uncer-
tain about the appropriateness of screening vulnerable
older people, whereas they considered screening of older
persons with good vitality for the same condition to be
Table 3. Appropriateness of Screening to Prevent Functional Decline in the General Older Population, Vital Older
Persons, and Vulnerable Older Persons, Stratified According to Age






60–74 75–84 85 60–74 75–84 85 60–74 75–84 85
At least one rating appropriate
Insufficient physical activity 7 7 7 7 7 7 7 7 7
Smoking status 7 6 4 7 6 4 6 5 3
Cardiovascular risk 7 3D 2 7 5D 2 4D 2 2
At least one rating uncertain
Burden of the screened person as informal caregiver 3 4 4 3 4 4 5 5 5
Hearing impairment 4 4 4 2 2 2 5 5 5
Urinary incontinence 3 3 3 3 4 4 5 5 5
Colorectal cancer 5 4 2 6 5 2 3 3 2
Burden of informal caregivers around the screened person 1 2 2 1 1 2 5D 5D 5D
Cognitive impairment or dementia 2 2 2 1 1 1 5 5 6
Depression and anxiety 2 2 2 2 2 2 5 5 5
Functional status 3 3 3 2 2 2 5 5 5
Loneliness 2 2 2 2 2 2 5 5 5
Malnutrition 2 2 2 2 2 2 4D 4D 4D
Pain 2 2 2 1 1 1 5 5 5
Polypharmacy 2 2 2 2 2 2 5 5 5
Undernutrition 3 3 3 2 2 2 5 5 5
Visual impairment 2 2 2 2 2 2 6 6 6
Abdominal aortic aneurysm in (ex‐)smoking men 4 2 2 5 3 2 2 2 1
All ratings inappropriate
Abdominal aortic aneurysm 2 1 1 2 1 1 1 1 1
Alcohol misuse 2 2 2 2 2 2 2 2 2
Chronic kidney disease 2 2 2 2 2 2 3 3 3
Diabetes mellitus 3 3 2 3 3 2 2 2 2
Falls 2 2 2 2 2 2 3 3 3
Skin cancer 1 1 1 1 1 1 1 1 1
Osteoporosis 1 1 1 1 1 1 2 2 2
Overweight 2 2 2 3 3 3 2 2 2
Sleep disorders 2 2 2 2 2 2 3 3 3
Smelling problems 1 1 1 1 1 1 1 1 1
Speech problems 1 1 1 1 1 1 1 1 1
* Ranked according to appropriateness and alphabetically.
† Range: 1–3, inappropriate; range: 4–6, uncertain; range: 7–9, appropriate.
D = disagreement: at least three panelists rated in the 1–3 range and at least three panelists rated in the 7–9 range.
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inappropriate. Because of lack of research data on the
vulnerable group, the panelists had to rely on their expert
opinion to rate these screening options. They expect bene-
fit from screening when more tests and interventions are
developed for this group. Because the majority of vulnera-
ble older people already receive medical care for their
chronic disease(s), the panelists expected more benefit
from improving regular care than from a separate screen-
ing program.
Age played a small role during the panel discussions.
Appropriateness of screening was modified according to
age for only six conditions: smoking status, cardiovascular
risk, abdominal aortic aneurysm in (ex-)smoking men,
colorectal cancer, burden of the screened person as infor-
mal caregiver, and urinary incontinence. A possible expla-
nation for this is the relationship between age and
vulnerability, with the latter being the discriminating
factor in rating.
Some guidelines5,7,11,13 claim that their recommenda-
tions are based on the criteria of Wilson and Jungner,
although there are marked differences between the recom-
mendations in these guidelines. A possible explanation for
the differences in these guidelines is a difference in the
validity of the guideline procedures. For example, the
Vilans guidebook,7 which contains the most positive advice,
is a descriptive protocol of available screening conditions
for older people rather than an evidence-based screening
guideline. Also, considerable differences may exist between
countries in the interpretation of evidence because of cul-
tural differences and differences in healthcare systems,
which influence recommendations in the guidelines.35 The
validity of the guideline processes (e.g., using the Appraisal
of Guidelines, Research, and Evaluation in Europe
(AGREE) instrument)36 was not formally assessed in the
present study, because the main focus was determination of
the appropriateness of screening by the expert panel.
Comparison of the outcome of the RAND/UCLA
appropriateness method with the recommendations of the
various guidelines shows considerable differences between
guidelines. The panel rating was more in accordance with
the European guidelines than with the U.S. and Australian
guidelines, probably because of an underlying cultural dif-
ference; (e.g., when evidence is lacking, Dutch healthcare
professionals tend to rely on the adage primum non
nocere, to defend patients from iatrogenic harm). Vulnerable
older people are at higher risk for expected and unexpected
side effects of confirmatory testing that follow a screening
test and subsequent treatment.4 In addition, organization of
care and healthcare availability may play a role; all inhabit-
ants in the Netherlands have healthcare insurance, and
almost everyone is registered with one general practice
over many years. People aged 75 and older contact their
general practitioner more than 16 times a year,37 which
often allows the general practitioner to detect relevant
changes in and problems with the aging process on a
personal level.
Osteoporosis, for example, is a condition in which
these cultural and healthcare differences played a role in
the panelists’ discussions. For osteoporosis, earlier research
resulted in evidence-based methods to identify risk for
osteoporotic fractures and effective medications to reduce
fractures, but as the U.S. Preventive Services Task Force
showed in its review of July 2010,38 no trials have directly
evaluated screening effectiveness, harms, and intervals
between screening. This lack of direct evidence leaves
room for weighing and interpretation, apparently resulting
in the overall finding that European guidelines contained
negative advice to screen for osteoporosis, whereas the
non-European guidelines recommended screening. In the
present study, the panelists considered that, in the Nether-
lands, assessment of osteoporosis was already part of treat-
ment in older people after fracture. In people using
corticosteroids for a prolonged period, prevention and
treatment of osteoporosis also form part of the therapeutic
plan. This means that the high-risk groups are already
assessed in the context of “normal” care. Only older peo-
ple without a fracture and without use of corticosteroids
are still unscreened. For this low-risk group, the panelists
argued that, although screening for osteoporosis in general
has not been proven to be effective, screening in this
remaining low-risk group will be even less effective. There-
fore, according to the panelists, there is insufficient evi-
dence to support screening for osteoporosis, especially
regarding the screening test (too many false negatives in
this low-risk group; Wilson and Jungner criterion 5).
Strengths and Limitations
The present study has several strengths. First, the focus on
healthy aging by preventing functional decline is relatively
new in studies on screening. In this study, the objective of
screening older people was not primarily to prevent and
postpone disease and death but rather to support the abil-
ity of older people to function as independently as possi-
ble.18 The results of the study indicate the need for more
high-quality studies to support the benefit of screening to
prevent functional decline. Another strength is the multi-
disciplinary panel, because the composition of the panel is
known to influence the outcome of the RAND/UCLA
appropriateness method.39 Most users of the RAND/UCLA
method recommend using a multidisciplinary panel to bet-
ter reflect the variety of specialties involved in decisions on
treatment.22 If another panel in which the composition in
terms of disciplines is maintained repeats the same proce-
dure, the results will be reproduced with a high level of
agreement.27,30,40 In the present study, the initial disagree-
ment in the first round (23%) meant that the panel com-
position adequately reflected the different opinions about
screening in health care. During the discussion, all
panelists were engaged in a positive-critical way and were
willing to change their opinion, if necessary.
One limitation of the present study is the specific
Dutch context in which the RAND/UCLA appropriateness
method was used; this might influence generalizability. It
would be interesting if panels in other countries would
replicate this study in order to compare the findings.
Another limitation is that it was not feasible to per-
form exhaustive systematic reviews for all 29 conditions
for all 10 criteria of Wilson and Jungner. Instead, the lit-
erature on which the guidelines were based was collected,
and experts were invited to complete and update these
files with recent literature. This practical approach is
in accordance with the RAND/UCLA appropriateness
method.22
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Clinical Implications and Future Research
The results of the RAND/UCLA appropriateness method
indicate that, according to the panelists, only screening of
the general older population for insufficient physical activ-
ity, smoking status, and cardiovascular risk in specific
groups is recommended to prevent functional decline. The
uncertain or inappropriate rating of the remaining screen-
ing conditions does not mean that the conditions are not
relevant but that there is insufficient evidence to recom-
mend an active screening approach at the population level.
For the conditions rated uncertain, mostly regarding the
vulnerable older population, evidence was lacking,
although based on their clinical experience, the panelists
expected potential benefit from screening embedded in the
regular care for this group of older people. It is important
in future research to detect effective screening approaches
and subsequent treatments to maintain functional status
and related quality of life for this group. Then, screening
and monitoring as part of regular care will support health-
ier aging by preventing or delaying functional decline.
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